Astellas Pharma Ltd

3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419583
Medical Information Direct Line: 0800 783 5018
Medical Information e-mail: medinfo@gb.astellas.com

Patient Information Leaflet last updated on the eMC: 03/11/2011
PIL Vesicare 5mg and 10mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to MA holder contact details
Updated on 22/02/2010 and displayed until 03/11/2011
Reasons for adding or updating:
  • Individual presentations superseded by joint PIL
  • Change to storage instructions
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 23/09/2008 and displayed until 22/02/2010
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
  • Change to side-effects
Updated on 22/02/2007 and displayed until 23/09/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 03/11/2006 and displayed until 22/02/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   solifenacin succinate